CD80	NN	B-NP	B-protein	B-Protein	No	No	B-Protein	Other	###	1	CD80	CD80	NN	NN	_	2	compound	_	_
upregulation	NN	I-NP	O	Other	No	No	Other	B-Positive_regulation	###	2	upregulation	upregulation	NN	NN	_	0	root	_	_
and	CC	O	O	Other	No	No	Other	Other	###	3	and	and	CC	CC	_	2	cc	_	_
flow	NN	B-NP	O	Other	No	No	Other	Other	###	4	flow	flow	NN	NN	_	5	compound	_	_
cytometry	NN	I-NP	O	Other	No	No	Other	Other	###	5	cytometry	cytometry	NN	NN	_	2	conj	_	_

Cells	NNS	B-NP	O	Other	No	No	Other	Other	###	1	Cells	Cells	NNS	NNS	_	9	nsubjpass	_	_
(	(	O	O	Other	No	No	Other	Other	###	2	(	(	(	(	_	3	punct	_	_
5x104	CD	B-NP	O	Other	No	No	Other	Other	###	3	5x104	5x104	CD	CD	_	1	dep	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	4	in	in	IN	IN	_	6	case	_	_
2	CD	B-NP	O	Other	No	No	Other	Other	###	5	2	2	CD	CD	_	6	nummod	_	_
ml	NN	I-NP	O	Other	No	No	Other	Other	###	6	ml	ml	NN	NN	_	3	nmod	_	_
)	)	O	O	Other	No	No	Other	Other	###	7	)	)	)	)	_	3	punct	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	8	were	were	VBD	VBD	_	9	auxpass	_	_
cultured	VBN	I-VP	O	Other	No	No	Other	Other	###	9	cultured	cultured	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	10	in	in	IN	IN	_	12	case	_	_
24-well	JJ	B-NP	O	Other	No	No	Other	Other	###	11	24-well	24-well	JJ	JJ	_	12	amod	_	_
plates	NNS	I-NP	O	Other	No	No	Other	Other	###	12	plates	plates	NNS	NNS	_	9	nmod	_	_
for	IN	B-PP	O	Other	No	No	Other	Other	###	13	for	for	IN	IN	_	15	case	_	_
3	CD	B-NP	O	Other	No	No	Other	Other	###	14	3	3	CD	CD	_	15	nummod	_	_
days	NNS	I-NP	O	Other	No	No	Other	Other	###	15	days	days	NNS	NNS	_	9	nmod	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	16	with	with	IN	IN	_	21	case	_	_
5	CD	B-NP	O	Other	No	No	Other	Other	###	17	5	5	CD	CD	_	18	nummod	_	_
microg	NN	I-NP	O	Other	No	No	Other	Other	###	18	microg	microg	NN	NN	_	21	compound	_	_
/	/	O	O	Other	No	No	Other	Other	###	19	/	/	/	/	_	21	punct	_	_
ml	NN	I-NP	O	Other	No	No	Other	Other	###	20	ml	ml	NN	NN	_	21	compound	_	_
anti-CD40	NN	I-NP	B-protein	Other	No	No	Other	Other	###	21	anti-CD40	anti-CD40	NN	NN	_	15	nmod	_	_
or	CC	O	O	Other	No	No	Other	Other	###	22	or	or	CC	CC	_	21	cc	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	23	an	an	DT	DT	_	26	det	_	_
isotype	NN	I-NP	B-protein	Other	No	No	Other	Other	###	24	isotype	isotype	NN	NN	_	26	compound	_	_
control	NN	I-NP	I-protein	Other	No	No	Other	Other	###	25	control	control	NN	NN	_	26	compound	_	_
antibody	NN	I-NP	I-protein	Other	No	No	Other	Other	###	26	antibody	antibody	NN	NN	_	21	conj	_	_
.	.	O	O	Other	No	No	Other	Other	###	27	.	.	.	.	_	9	punct	_	_

Cells	NNS	B-NP	O	Other	No	No	Other	Other	###	1	Cells	Cells	NNS	NNS	_	3	nsubjpass	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	2	were	were	VBD	VBD	_	3	auxpass	_	_
stained	VBN	I-VP	O	Other	No	No	Other	Other	###	3	stained	stained	VBN	VBN	_	0	root	_	_
for	IN	B-PP	O	Other	No	No	Other	Other	###	4	for	for	IN	IN	_	6	case	_	_
flow	NN	B-NP	O	Other	No	No	Other	Other	###	5	flow	flow	NN	NN	_	6	compound	_	_
cytometry	NN	I-NP	O	Other	No	No	Other	Other	###	6	cytometry	cytometry	NN	NN	_	3	nmod	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	7	with	with	IN	IN	_	8	case	_	_
FITC-anti-CD80	NN	B-NP	B-protein	Other	No	No	Other	Other	###	8	FITC-anti-CD80	FITC-anti-CD80	NN	NN	_	6	nmod	_	_
or	CC	O	O	Other	No	No	Other	Other	###	9	or	or	CC	CC	_	8	cc	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	10	an	an	DT	DT	_	13	det	_	_
appropriate	JJ	I-NP	O	Other	No	No	Other	Other	###	11	appropriate	appropriate	JJ	JJ	_	13	amod	_	_
control	NN	I-NP	O	Other	No	No	Other	Other	###	12	control	control	NN	NN	_	13	compound	_	_
antibody	NN	I-NP	O	Other	No	No	Other	Other	###	13	antibody	antibody	NN	NN	_	8	conj	_	_
as	IN	B-SBAR	O	Other	No	No	Other	Other	###	14	as	as	IN	IN	_	15	mark	_	_
described	VBN	B-VP	O	Other	No	No	Other	Other	###	15	described	described	VBN	VBN	_	3	advcl	_	_
[	(	O	O	Other	No	No	Other	Other	###	16	[	[	(	(	_	18	auxpass	_	_
28	CD	B-NP	O	Other	No	No	Other	Other	###	17	28	28	CD	CD	_	18	nummod	_	_
]	)	O	O	Other	No	No	Other	Other	###	18	]	]	)	)	_	15	xcomp	_	_
.	.	O	O	Other	No	No	Other	Other	###	19	.	.	.	.	_	3	punct	_	_

Data	NNS	B-NP	O	Other	No	No	Other	Other	###	1	Data	Data	NNS	NNS	_	13	nsubjpass	_	_
acquired	VBN	B-VP	O	Other	No	No	Other	Other	###	2	acquired	acquired	VBN	VBN	_	1	acl	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	3	with	with	IN	IN	_	7	case	_	_
a	DT	B-NP	O	Other	No	No	Other	Other	###	4	a	a	DT	DT	_	7	det	_	_
FACScan	NN	I-NP	O	Other	No	No	Other	Other	###	5	FACScan	FACScan	NN	NN	_	7	compound	_	_
flow	NN	I-NP	O	Other	No	No	Other	Other	###	6	flow	flow	NN	NN	_	7	compound	_	_
cytometer	NN	I-NP	O	Other	No	No	Other	Other	###	7	cytometer	cytometer	NN	NN	_	2	nmod	_	_
(	(	O	O	Other	No	No	Other	Other	###	8	(	(	(	(	_	10	punct	_	_
BD	NN	B-NP	O	Other	No	No	Other	Other	###	9	BD	BD	NN	NN	_	10	compound	_	_
Biosciences	NNS	I-NP	O	Other	No	No	Other	Other	###	10	Biosciences	Biosciences	NNS	NNS	_	7	appos	_	_
)	)	O	O	Other	No	No	Other	Other	###	11	)	)	)	)	_	10	punct	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	12	were	were	VBD	VBD	_	13	auxpass	_	_
analyzed	VBN	I-VP	O	Other	No	No	Other	Other	###	13	analyzed	analyzed	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	14	with	with	IN	IN	_	15	case	_	_
WinMDI	NNP	B-NP	O	Other	No	No	Other	Other	###	15	WinMDI	WinMDI	NNP	NNP	_	13	nmod	_	_
2.8	CD	I-NP	O	Other	No	No	Other	Other	###	16	2.8	2.8	CD	CD	_	15	nummod	_	_
(	(	O	O	Other	No	No	Other	Other	###	17	(	(	(	(	_	20	punct	_	_
Scripps	NNP	B-NP	O	Other	No	No	Other	Other	###	18	Scripps	Scripps	NNP	NNP	_	20	compound	_	_
Research	NNP	I-NP	O	Other	No	No	Other	Other	###	19	Research	Research	NNP	NNP	_	20	compound	_	_
Institute	NNP	I-NP	O	Other	No	No	Other	Other	###	20	Institute	Institute	NNP	NNP	_	15	dep	_	_
,	,	O	O	Other	No	No	Other	Other	###	21	,	,	,	,	_	20	punct	_	_
San	NNP	B-NP	O	Other	No	No	Other	Other	###	22	San	San	NNP	NNP	_	23	compound	_	_
Diego	NNP	I-NP	O	Other	No	No	Other	Other	###	23	Diego	Diego	NNP	NNP	_	20	appos	_	_
,	,	O	O	Other	No	No	Other	Other	###	24	,	,	,	,	_	20	punct	_	_
CA	NNP	B-NP	O	Other	No	No	Other	Other	###	25	CA	CA	NNP	NNP	_	20	appos	_	_
)	)	O	O	Other	No	No	Other	Other	###	26	)	)	)	)	_	20	punct	_	_
.	.	O	O	Other	No	No	Other	Other	###	27	.	.	.	.	_	13	punct	_	_

